1. Home
  2. ETG vs COLL Comparison

ETG vs COLL Comparison

Compare ETG & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest

ETG

Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest

HOLD

Current Price

$23.40

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$44.14

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETG
COLL
Founded
2003
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ETG
COLL
Price
$23.40
$44.14
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$51.17
AVG Volume (30 Days)
132.1K
512.5K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
6.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
N/A
$757,067,000.00
Revenue This Year
N/A
$26.17
Revenue Next Year
N/A
$3.65
P/E Ratio
N/A
$28.19
Revenue Growth
N/A
26.34
52 Week Low
$14.08
$23.23
52 Week High
$18.34
$50.79

Technical Indicators

Market Signals
Indicator
ETG
COLL
Relative Strength Index (RSI) 61.16 41.31
Support Level $22.45 $44.43
Resistance Level $23.47 $48.29
Average True Range (ATR) 0.23 2.15
MACD -0.02 -0.30
Stochastic Oscillator 90.21 15.93

Price Performance

Historical Comparison
ETG
COLL

About ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest

Eaton Vance Tax Advgd Gbl Div Inc Fd is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of aerospace and defense, capital markets, diversified telecommunication services, electrical equipment, biotechnology, banks, and other areas.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: